EvidenceCare, a Nashville, Tenn.-based clinical decision support tool for healthcare providers, closed $2M convertible Note B funding.
NueCura Partners made the investment.
The company, which has raised more than $3M in total funding, intends to use the capital to accelerate the development of its enterprise offering and launch it this summer.
Led by Chief Executive Officer Brian Fengler, MD, and COO Jim Jamieson, EvidenceCare provides a clinical decision support platform for clinicians to access patient specific evidence-based treatment recommendations at the bedside in as little as 30 seconds. Since its launch in July 2016, the company’s proprietary content publishing platform is delivering protocols authored by experts to nearly 1800 providers worldwide.